90 related articles for article (PubMed ID: 14746021)
1. Cervical cancer prevention: the case of developing countries.
Mohar A
Salud Publica Mex; 2003; 45 Suppl 3():S301-3. PubMed ID: 14746021
[No Abstract] [Full Text] [Related]
2. Low cost methods for secondary prevention of cervical cancer in developing countries.
Anorlu RI; Ola ER; Abudu OO
Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer prevention in the developing world.
Park IU; Diaz ML; Bowey C; Magaril R; Ferris DG;
J Low Genit Tract Dis; 2007 Oct; 11(4):273. PubMed ID: 17917572
[No Abstract] [Full Text] [Related]
4. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
Suba EJ
Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750
[TBL] [Abstract][Full Text] [Related]
5. Experts inject reality into cervical cancer prevention schemes.
Padma TV
Nat Med; 2005 Apr; 11(4):359. PubMed ID: 15812499
[No Abstract] [Full Text] [Related]
6. [Model of a program for the prevention and detection of gynecologic cancer in developing countries].
Goes Júnior JS; Goes JC
AMB Rev Assoc Med Bras; 1980 Dec; 26(12):411-6. PubMed ID: 6973785
[No Abstract] [Full Text] [Related]
7. Chapter 8: Screening for cervical cancer in developing countries.
Denny L; Quinn M; Sankaranarayanan R
Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020
[TBL] [Abstract][Full Text] [Related]
8. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer].
Stekelenburg J; Schagen van Leeuwen J
Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1701-2; author reply 1702. PubMed ID: 18717015
[No Abstract] [Full Text] [Related]
9. Papanicolaou screening in developing countries: an idea whose time has come.
Suba EJ; Raab SS;
Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
[TBL] [Abstract][Full Text] [Related]
10. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9].
Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549
[No Abstract] [Full Text] [Related]
11. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
Suba EJ; Donnelly AD; Furia LM; Huynh ML; Raab SS;
Diagn Cytopathol; 2007 Mar; 35(3):187-91. PubMed ID: 17304532
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer vaccines. Introduction of vaccines that prevent cervical cancer and genital warts may fore-shadow implementation and acceptability issues for a future AIDS vaccines.
Kresge KJ
IAVI Rep; 2005; 9(5):1-5. PubMed ID: 16541499
[No Abstract] [Full Text] [Related]
14. Screening and prevention: cervical cancer.
Weinstein LC; Buchanan EM; Hillson C; Chambers CV
Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer: the sub-Saharan African perspective.
Anorlu RI
Reprod Health Matters; 2008 Nov; 16(32):41-9. PubMed ID: 19027621
[TBL] [Abstract][Full Text] [Related]
16. Screening the only option to prevent cervical cancer.
JNMA J Nepal Med Assoc; 2005; 44(159):I. PubMed ID: 16554856
[No Abstract] [Full Text] [Related]
17. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
Kohl I
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer in the developing world.
Zeferino LC; Derchain SF
Best Pract Res Clin Obstet Gynaecol; 2006 Jun; 20(3):339-54. PubMed ID: 16563869
[TBL] [Abstract][Full Text] [Related]
19. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
[TBL] [Abstract][Full Text] [Related]
20. The future of cervical cancer prevention in Europe.
Davies P; Bogdanovic-Guillion A; Grce M; Sancho-Garnier H
Coll Antropol; 2007 Apr; 31 Suppl 2():11-6. PubMed ID: 17598500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
